Free Trial

Bavarian Nordic (OTCMKTS:BVNRY) Share Price Passes Above Fifty Day Moving Average - Here's Why

Bavarian Nordic logo with Medical background

Key Points

  • Bavarian Nordic's share price surpassed its 50-day moving average of $11.39, hitting a high of $12.27 during trading, indicating strong market momentum.
  • The company reported $251.14 million in revenue and $0.23 earnings per share for the most recent quarter, highlighting its financial stability.
  • Bavarian Nordic has a market capitalization of $2.90 billion and is involved in the development of life-saving vaccines, including those for smallpox and rabies.
  • Interested in Bavarian Nordic? Here are five stocks we like better.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $11.39 and traded as high as $12.27. Bavarian Nordic shares last traded at $12.27, with a volume of 592 shares.

Bavarian Nordic Stock Performance

The firm has a market capitalization of $2.90 billion, a P/E ratio of 14.10 and a beta of 1.30. The business has a 50 day simple moving average of $11.39 and a two-hundred day simple moving average of $9.25.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) last announced its earnings results on Friday, August 22nd. The company reported $0.23 earnings per share for the quarter. The business had revenue of $251.14 million for the quarter. Bavarian Nordic had a return on equity of 12.35% and a net margin of 21.95%. On average, equities analysts anticipate that Bavarian Nordic will post 0.67 earnings per share for the current fiscal year.

Bavarian Nordic Company Profile

(Get Free Report)

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bavarian Nordic Right Now?

Before you consider Bavarian Nordic, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic wasn't on the list.

While Bavarian Nordic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.